Advancements In Capsid Engineering For Targeted Central Nervous System (CNS) Gene Therapy Is Playing A Role In Shaping The Nuclear Medicine Radioisotopes Market
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Growth In Market Value Is Expected For The Nuclear Medicine Radioisotopes Market Between 2026 And 2030?
The nuclear medicine radioisotopes market has seen substantial expansion in recent years. It is anticipated to expand from $8.85 billion in 2025 to $9.58 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.2%. This historical growth can be linked to the extensive utilization of technetium-99m in diagnostic imaging, the increasing adoption of nuclear cardiology procedures, the rising occurrence of cancer and thyroid disorders, the growth of hospital-based nuclear medicine departments, and the early favorable outcomes of radioisotope-based therapies.
The nuclear medicine radioisotopes market size is anticipated to experience significant growth in the upcoming years. It is projected to expand to $12.75 billion by 2030, achieving a compound annual growth rate (CAGR) of 7.4%. This expected growth can be attributed to factors such as the increasing demand for personalized cancer treatment, the rising application of lutetium-177 and actinium-225 therapies, the expansion of PET imaging infrastructure, growing investments in cyclotron and reactor facilities, and the increasing adoption of nuclear medicine in emerging economies. Major trends foreseen for this period include the rising acceptance of theranostics in oncology care, a growing demand for PET and SPECT imaging procedures, increased use of targeted alpha and beta emitters, the expansion of nuclear medicine into cardiology and neurology, and an enhanced focus on domestic radioisotope production.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16132&type=smp
What Key Drivers Are Fueling The Growth Of The Nuclear Medicine Radioisotopes Market?
An anticipated expansion in the nuclear medicine radioisotope market is linked to the increasing incidence of cardiovascular diseases. Cardiovascular diseases encompass various conditions impacting the heart and circulatory system. The growing prevalence of cardiovascular diseases stems from factors such as inactive lifestyles, unhealthy eating patterns, escalating obesity rates, and an aging demographic. Nuclear medicine radioisotopes play a crucial role in the diagnosis, assessment, and management of cardiovascular diseases, offering comprehensive data on cardiac performance, blood flow, and tissue health, all vital for precise diagnosis and successful therapeutic strategies. For example, in January 2024, the American Heart Association, a US-based non-profit organization, reported an increase in the age-adjusted death rate from cardiovascular disease to 233.3 per 100,000 in 2024, representing a 4.0% rise from 224.4 per 100,000 in 2023. Consequently, the escalating occurrences of cardiovascular diseases are fueling the expansion of the nuclear medicine radioisotope market.
What Are The Different Segment Types In The Nuclear Medicine Radioisotopes Market Segment Breakdown?
The nuclear medicine radioisotopes market covered in this report is segmented –
1) By Type: Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Fluorine-18, Rubidium-82 (Rb-82), Iodine-131 (I-131), Lutetium-177 (Lu-177), Radium-223 (Ra-223) And Alpharadin, Other Types
2) By Application: Oncology, Cardiology, Thyroid, Neurology, Other Applications
3) By End-User: Hospitals, Diagnostic Centers, Specialty Clinics, Education And Research Institutes, Other End-Users
Subsegments:
1) By Technetium-99m (Tc-99m): Sodium Pertechnetate Tc-99m, Tc-99m MDP (Methylene Diphosphonate), Tc-99m HMPAO (Hexamethylpropyleneamine oxime)
2) By Thallium-201 (Tl-201): Thallous Chloride Tl-201, Thallium-201 for Cardiac Imaging
3) By Iodine-123 (I-123): Iodine-123 Sodium Iodide, Iodine-123 Ioflupane (DaTscan)
4) By Fluorine-18: FDG (Fluorodeoxyglucose) F-18, Fluoride-18 For Bone Imaging
5) By Rubidium-82 (Rb-82): Rb-82 For PET (Positron Emission Tomography) Imaging, Rb-82 For Cardiac Imaging
6) By Iodine-131 (I-131): I-131 Sodium Iodide, I-131 For Thyroid Cancer Treatment, I-131 For Hyperthyroidism Treatment
7) By Lutetium-177 (Lu-177): Lu-177-DOTATATE, Lu-177 For Prostate Cancer Treatment
8) By Radium-223 (Ra-223): Ra-223 Dichloride (Xofigo), Alpharadin For Bone Metastasis Treatment
9) By Alpharadin (Radium-223 Alpha Emitters): Ac-225 For Targeted Alpha Therapy (TAT), Ac-225 For Cancer Treatment, Gallium-68 (Ga-68), Copper-64 (Cu-64), Yttrium-90 (Y-90)
10) By Other Types: Ac-225 For Targeted Alpha Therapy (TAT), Ac-225 For Cancer Treatment, Gallium-68 (Ga-68), Copper-64 (Cu-64), Yttrium-90 (Y-90)
What Trends Are Affecting The Growth Of The Nuclear Medicine Radioisotopes Market?
Leading companies in the nuclear medicine radioisotopes market are concentrating on developing innovative solutions, such as next-generation theranostic radiopharmaceuticals, to improve the precision of imaging and the effectiveness of targeted treatment. These advanced theranostic radiopharmaceuticals are sophisticated radioactive agents designed to both detect and accurately treat diseases by specifically targeting cells within the body with high precision. For example, in November 2025, the University of California, a US-based research university, established an entirely independent Department of Nuclear Medicine & Theranostics, rather than maintaining nuclear medicine within a broader radiology framework. This new department aims to accelerate the integration of advanced imaging and targeted radiopharmaceutical therapies. It also works to strengthen research, education, and clinical programs to advance precision medicine and foster innovations in theranostic treatments.
Who Are The Well-Known Companies In The Nuclear Medicine Radioisotopes Market?
Major companies operating in the nuclear medicine radioisotopes market are Cardinal Health Inc., Bayer AG, Siemens Healthineers AG, GE HealthCare Technologies, BWX Technologies Inc., Mallinckrodt Pharmaceuticals, Bracco Imaging S.p.A., Lantheus Holdings Inc., Curium Pharma, Australian Nuclear Science and Technology Organisation (ANSTO) Health, Eckert & Ziegler Strahlen, NorthStar Medical Radioisotopes, NTP Radioisotopes, Shine Medical Technologies Inc., Jubilant DraxImage Inc., Isotopia Molecular Imaging Ltd., Eczacibasi-Monrol Nuclear Products, International Isotopes Inc., Polatom Sp. z o.o., Radiomedix Inc., Positron Corporation
Get The Full Nuclear Medicine Radioisotopes Market Report:
Where Is The Nuclear Medicine Radioisotopes Market Primarily Concentrated By Region?
North America was the largest region in the nuclear medicine radioisotopes market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nuclear medicine radioisotopes market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Nuclear Medicine Radioisotopes Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Nuclear Medicine Radioisotopes Market 2026, By The Business Research Company
Nuclear Medicine Radioisotopes Market Report 2026
Diagnostic Radioisotopes Market Report 2026
https://www.thebusinessresearchcompany.com/report/diagnostic-radioisotopes-global-market-report
Nuclear Medicine Market Report 2026
https://www.thebusinessresearchcompany.com/report/nuclear-medicine-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
